NF-κB -94Ins/Del ATTG polymorphism modifies the association between dietary polyunsaturated fatty acids and HDL-cholesterol in two distinct populations

Atherosclerosis

Volumn 204, Issue 2, 2009, Pages 465-470

  Fontaine Bisson, Bénédicte ^a   Wolever, Thomas M S ^a,b   Connelly, Philip W ^a,b   Corey, Paul N ^c   El Sohemy, Ahmed ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b ST MICHAEL'S HOSPITAL   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

HDL cholesterol; NF B; Polymorphism; Polyunsaturated fatty acids

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; POLYUNSATURATED FATTY ACID; NFKB1 PROTEIN, HUMAN; UNSATURATED FATTY ACID;

ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIETARY INTAKE; DISEASE ASSOCIATION; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; BLOOD; CANADA; CLINICAL TRIAL; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; DIET THERAPY; FAT INTAKE; GENETIC POLYMORPHISM; GENETICS; MIDDLE AGED; MULTICENTER STUDY; PHENOTYPE;

ADULT; AGED; CANADA; CHOLESTEROL, HDL; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; DIETARY FATS; FATTY ACIDS, UNSATURATED; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; NF-KAPPA B P50 SUBUNIT; PHENOTYPE; POLYMORPHISM, GENETIC; YOUNG ADULT;

EID: 67349103342     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2008.10.037     Document Type: Article

References (32)

1. Link J., Rohatgi A., and de Lemos J.A. HDL cholesterol: physiology, pathophysiology, and management. Curr Probl Cardiol 32 (2007) 268-314
2. Grunfeld C., and Feingold K.R. HDL and innate immunity: a tale of two apolipoproteins. J Lipid Res 49 (2008) 1605-1606
3. Grimble R. Dietary lipids and the inflammatory response. Proc Nutr Soc 57 (1998) 535-542
4. Calder P. Polyunsaturated fatty acids and inflammation. Prostaglandins Leukot Essent Fatty Acids 75 (2006) 197-202
5. Wijendran V., and Hayes K.C. Dietary n - 6 and n - 3 fatty acid balance and cardiovascular health. Annu Rev Nutr 24 (2004) 597-615
6. Ordovas J., Corella D., Cupples L.A., et al. Polyunsaturated fatty acids modulate the effects of the APOA1 G-A polymorphism on HDL-cholesterol concentrations in a sex-specific manner: the Framingham Study. Am J Clin Nutr 75 (2002) 38-46
7. Fontaine-Bisson B., Wolever T.M.S., Chiasson J.L., et al. Genetic polymorphisms of tumor necrosis factor-α modify the association between dietary polyunsaturated fatty acids and fasting HDL-cholesterol and apo A-I concentrations. Am J Clin Nutr 86 (2007) 768-774
8. Fontaine-Bisson B., and El-Sohemy A. Genetic polymorphisms of tumor necrosis factor-alpha modify the association between dietary polyunsaturated fatty acids and plasma high-density lipoprotein-cholesterol concentrations in a population of young adults. J Nutrigenet Nutrigenom 1 (2008) 215-223
9. Kumar A., Takada Y., Boriek A.M., and Aggarwal B.B. Nuclear factor-kappaB: its role in health and disease. J Mol Med 82 (2004) 434-448
10. Zhao Y., Joshi-Barve S., Barve S., and Chen L.H. Eicosapentaenoic acid prevents LPS-induced TNF-alpha expression by preventing NF-kappaB activation. J Am Coll Nutr 23 (2004) 71-78
11. Wang J., Ma H., Wang J., Li Q., Li Y., and Li J. Long-term n - 3 polyunsaturated fatty acids administration ameliorates arteriosclerosis by modulating T-cell activity in a rat model of small intestine transplantation. Clin Chim Acta 381 (2007) 124-130
12. Camandola S., Leonarduzzi G., Musso T., et al. Nuclear factor kB is activated by arachidonic acid but not by eicosapentaenoic acid. Biochem Biophys Res Commun 229 (1996) 643-647
13. Maziere C., Conte M.A., Degonville J., Ali D., and Maziere J.C. Cellular enrichment with polyunsaturated fatty acids induces an oxidative stress and activates the transcription factors AP1 and NFkappaB. Biochem Biophys Res Commun 265 (1999) 116-122
14. Karban A., Okazaki T., Panhuysen C.I., et al. Functional annotation of a novel NFKB1 promoter polymorphism that increases risk for ulcerative colitis. Hum Mol Genet 13 (2004) 35-45
15. Park J., Farrance I.K., Fenty N.M., et al. NFKB1 promoter variation implicates shear-induced NOS3 gene expression and endothelial function in prehypertensives and stage I hypertensives. Am J Physiol Heart Circ Physiol 293 (2007) H2320-H2327
16. Pickup J. Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabetes Care 27 (2004) 813-823
17. Fontaine-Bisson B., Wolever T.M.S., Chiasson J.L., et al. TNF-α 238G > A genotype alters post-prandial plasma levels of free fatty acids in obese individuals with type 2 diabetes. Metabolism 56 (2007) 649-655
18. Canadian nutrient file. Ottawa; 1997.
19. Sniderman A., Blank D., Zakarian R., Bergeron J., and Frohlich J. Triglycerides and small dense LDL: the twin Achilles heels of the Friedewald formula. Clin Biochem 36 (2003) 499-504
20. Willet W. Nutritional epidemiology. second edn (1998), Oxford University Press, New York
21. Das U. Biological significance of essential fatty acids. JAPI 54 (2006) 309-319
22. Lee J., Sohn K.H., Rhee S.H., and Hwang D. Saturated fatty acids, but not unsaturated fatty acids, induce the expression of cyclooxygenase-2 mediated through Toll-like receptor 4. J Biol Chem 276 (2001) 16683-16689
23. Zhao G., Etherton T.D., Martin K.R., et al. Anti-inflammatory effects of polyunsaturated fatty acids in THP-1 cells. Biochem Biophys Res Commun 336 (2005) 909-917
24. Kurylowicz A., Hiromatsu Y., Jurecka-Lubieniecka B., et al. Association of NFKB1-94ins/del ATTG promoter polymorphism with susceptibility to and phenotype of Graves' disease. Genes Immun 8 (2007) 532-538
25. Baer M., Dillner A., Schwartz R.C., Sedon C., Nedospasov S., and Johnson P.F. Tumor necrosis factor alpha transcription in macrophages is attenuated by an autocrine factor that preferentially induces NF-kappaB p50. Mol Cell Biol 18 (1998) 5678-5689
26. Hotamisligil G. Inflammation and metabolic disorders. Nature 444 (2006) 860-867
27. Morishima A., Ohkubo N., Maeda N., Miki T., and Mitsuda N. NFkappaB regulates plasma apolipoprotein A-I and high density lipoprotein cholesterol through inhibition of peroxisome proliferator-activated receptor alpha. J Biol Chem 278 (2003) 38188-38193
28. Vanden Berghe W., Vermeulen L., Delerive P., De Bosscher K., Staels B., and Haegeman G. A paradigm for gene regulation: inflammation, NF-kappaB and PPAR. Adv Exp Med Biol 544 (2003) 181-196
29. Nissen S., Nicholls S.J., Wolski K., et al. Effects of a potent and selective PPAR-alpha agonist in patients with atherogenic dyslipidemia or hypercholesterolemia: two randomized controlled trials. JAMA 297 (2007) 1362-1373
30. Popa C., Netea M.G., Radstake T., et al. Influence of anti-tumour necrosis factor therapy on cardiovascular risk factors in patients with active rheumatoid arthritis. Ann Rheum Dis 64 (2005) 303-305
31. Bocos C., Göttlicher M., Gearing K., et al. Fatty acid activation of peroxisome proliferator-activated receptor (PPAR). J Steroid Biochem Mol Biol 53 (1995) 467-473
32. Paradis A., Fontaine-Bisson B., Bosse Y., et al. The peroxisome proliferator-activated receptor alpha Leu162Val polymorphism influences the metabolic response to a dietary intervention altering fatty acid proportions in healthy men. Am J Clin Nutr 81 (2005) 523-530